Literature DB >> 21656575

Functional NBS1 polymorphism is associated with occurrence and advanced disease status of nasopharyngeal carcinoma.

Jian Zheng1, Chun Zhang, Lan Jiang, Yonghe You, Yuehui Liu, Jiachun Lu, Yifeng Zhou.   

Abstract

As a component of the MRN (MRE11/RAD50/NBS1) complex, NBS1 plays an important role in cellular response to DNA damage and the maintenance of chromosomal integrity. The NBS1 E185Q polymorphism (8360G>C, rs1805794) has been frequently studied in some cancers with discordant results, but its association with nasopharyngeal carcinoma (NPC) in Chinese population has not been investigated. Moreover, there is no report about the association between NBS1 3'UTR variant rs2735383 and the risk of NPC. A multiple center case-control analysis was performed to assess the association between NBS1 polymorphisms and NPC risk in Eastern and Southern Chinese population. The genotypes and haplotypes were determined in 1052 cases and 1168 controls and the associations with risk of NPC were estimated by logistic regression. Cell migration assays were performed in 24-well transwell chambers to detect the effects of NBS1 E185Q SNP on cell migration. We observed significant difference in genotype frequencies at the rs1805794 C/G site between cases and controls (P(trend) < 0.0001). The C allele increases the risk for invasive disease or metastatic disease, compared with G allele. More over, CNE-2 cells (NPC cell line) transfected with pcDNA-NBS1-185Q (8360CC) had significantly higher migration levels than those transfected with pcDNA-NBS1-185E (8360GG) (P = 0.024). These findings suggest that E185Q polymorphism in NBS1 may be a genetic modifier for the occurrence and aggression of NPC.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656575     DOI: 10.1002/mc.20803

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  22 in total

1.  Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population.

Authors:  Ming-De Huang; Xiao-Fei Chen; Gang Xu; Qing-Quan Wu; Jian-Huai Zhang; Guo-Feng Chen; Yong Cai; Fu-Zhen Qi
Journal:  DNA Cell Biol       Date:  2011-11-09       Impact factor: 3.311

Review 2.  Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.

Authors:  Allan Hildesheim; Cheng-Ping Wang
Journal:  Semin Cancer Biol       Date:  2012-01-25       Impact factor: 15.707

3.  Polymorphisms of Toll-like receptor 9 are associated with nasopharyngeal carcinoma susceptibility.

Authors:  Qiong Dai; Xing Pu Li; Li Chai; Han An Long; Zhi Hui Yang
Journal:  Tumour Biol       Date:  2014-02-07

4.  Significant associations between GSTM1/GSTT1 polymorphisms and nasopharyngeal cancer risk.

Authors:  Yumei Wei; Tao Zhou; Haiqun Lin; Mingping Sun; Dongqing Wang; Hongsheng Li; Baosheng Li
Journal:  Tumour Biol       Date:  2012-12-30

5.  The association between -1304T>G polymorphism in the promoter of mitogen-activated protein kinase kinase 4 gene and the risk of cervical cancer in Chinese population.

Authors:  Min Hu; Jian Zheng; Liyuan Zhang; Lan Jiang; Yonghe You; Mingjun Jiang; Hua Li
Journal:  DNA Cell Biol       Date:  2012-02-15       Impact factor: 3.311

6.  DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1.

Authors:  Alina Rosinha; Joana Assis; Francisca Dias; Augusto Nogueira; Deolinda Pereira; Joaquina Maurício; Ana Luísa Teixeira; Rui Medeiros
Journal:  Med Oncol       Date:  2015-10-22       Impact factor: 3.064

7.  NBS1 rs1805794G>C polymorphism is associated with decreased risk of acute myeloid leukemia in a Chinese population.

Authors:  Na Li; Yanzhe Xu; Jian Zheng; Lan Jiang; Yonghe You; Hongchun Wu; Wei Li; Depei Wu; Yifeng Zhou
Journal:  Mol Biol Rep       Date:  2013-01-03       Impact factor: 2.316

8.  The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer.

Authors:  You-Hua Jiang; Xiao-Ling Xu; Hai-Hong Ruan; Wei-Zhen Xu; Dan Li; Jian-Guo Feng; Qian-Bo Han; Wei-Min Mao
Journal:  Med Oncol       Date:  2014-04-11       Impact factor: 3.064

9.  Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variation.

Authors:  Tingting Yang; Po-Yin Chang; Sungshim Lani Park; Delara Bastani; Shen-Chih Chang; Hal Morgenstern; Donald P Tashkin; Jenny T Mao; Jeanette C Papp; Jian-Yu Rao; Wendy Cozen; Thomas M Mack; Sander Greenland; Zuo-Feng Zhang
Journal:  Cancer Causes Control       Date:  2013-10-29       Impact factor: 2.506

10.  NBS1 Glu185Gln polymorphism and cancer risk: update on current evidence.

Authors:  Ya-Zhou He; Xiao-Sa Chi; Yuan-Chuan Zhang; Xiang-Bing Deng; Jia-Rong Wang; Wen-Yu Lv; Yan-Hong Zhou; Zi-Qiang Wang
Journal:  Tumour Biol       Date:  2013-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.